Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asim Khwaja

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Topics in Microbiology and Immunology|June 3, 2010
PI3K as a target for therapy in haematological malignanciesAsim Khwaja
British Journal of Haematology|July 11, 2006
The role of Janus kinases in haemopoiesis and haematological malignancyAsim Khwaja
JAAPA : Official Journal of the American Academy of Physician Assistants|January 10, 2008
Mechanical thrombolysis for deep vein thrombosisChristopher Davis, Asim Khwaja
Cancer Cell|March 22, 2014
PI3Kδ inhibition hits a sensitive spot in B cell malignanciesBart Vanhaesebroeck, Asim Khwaja
JAAPA : Official Journal of the American Academy of Physician Assistants|February 1, 2008
A telltale sign of fracture in a 74-year-old womanChristopher Davis, William Jacoby, Asim Khwaja
Journal of the Saudi Heart Association|April 30, 2019
Thyrocervical trunk perforation: A rare vascular complication during cardiac intervention through right radial approach: A case report and literature reviewMasood Ayyub Ghori, Abdulmajeed Al Zubaidi, Asim Khwaja
Cancer Research|January 30, 2009
Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiationClotilde Billottet, Lalita Banerjee, Bart Vanhaesebroeck, et al.
British Journal of Haematology|February 3, 2015
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibitionSteven Tinsley, Koremu Meja, Clare Shepherd, et al.
The Journal of Biological Chemistry|December 12, 2002
The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinasesLouise Tatton, Gary M Morley, Rajesh Chopra, et al.
British Journal of Haematology|March 5, 2003
Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsTim C P Somervaille, David C Linch, Asim Khwaja
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Topics in Microbiology and Immunology|June 3, 2010
PI3K as a target for therapy in haematological malignanciesAsim Khwaja
British Journal of Haematology|July 11, 2006
The role of Janus kinases in haemopoiesis and haematological malignancyAsim Khwaja
JAAPA : Official Journal of the American Academy of Physician Assistants|January 10, 2008
Mechanical thrombolysis for deep vein thrombosisChristopher Davis, Asim Khwaja
Cancer Cell|March 22, 2014
PI3Kδ inhibition hits a sensitive spot in B cell malignanciesBart Vanhaesebroeck, Asim Khwaja
JAAPA : Official Journal of the American Academy of Physician Assistants|February 1, 2008
A telltale sign of fracture in a 74-year-old womanChristopher Davis, William Jacoby, Asim Khwaja
Journal of the Saudi Heart Association|April 30, 2019
Thyrocervical trunk perforation: A rare vascular complication during cardiac intervention through right radial approach: A case report and literature reviewMasood Ayyub Ghori, Abdulmajeed Al Zubaidi, Asim Khwaja
Cancer Research|January 30, 2009
Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiationClotilde Billottet, Lalita Banerjee, Bart Vanhaesebroeck, et al.
British Journal of Haematology|February 3, 2015
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibitionSteven Tinsley, Koremu Meja, Clare Shepherd, et al.
The Journal of Biological Chemistry|December 12, 2002
The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinasesLouise Tatton, Gary M Morley, Rajesh Chopra, et al.
British Journal of Haematology|March 5, 2003
Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsTim C P Somervaille, David C Linch, Asim Khwaja
Pageof 7